Equity Capital Structure and Equity Incentive Plan (Details Narrative) - USD ($) | | | | | | | | | | | | | | 12 Months Ended | | | | | | |
Mar. 29, 2024 | May 11, 2023 | May 11, 2022 | Dec. 20, 2021 | Jul. 16, 2021 | May 27, 2021 | Apr. 02, 2021 | Mar. 11, 2021 | Feb. 24, 2021 | Jan. 04, 2021 | Dec. 20, 2020 | Oct. 13, 2020 | Oct. 08, 2020 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Oct. 13, 2023 | Aug. 23, 2021 | May 14, 2021 | Dec. 21, 2020 | Nov. 20, 2020 | Apr. 06, 2020 |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Common stock, shares authorized | | | | | | | | | | | | | | 450,000,000 | 450,000,000 | | | | | | | |
Common stock, shares authorized | | | | | | | | | | | | | | 50,000,000 | 50,000,000 | | | | | | | |
Common stock, shares issued | | | | | | | | | | | | | | 10,542,547 | 10,614,319 | | | | | | | |
Common stock, shares outstanding | | | | | | | | | | | | | | 10,542,547 | 10,614,319 | | | | | | | |
Preferred shares, par value | | | | | | | | | | | | | | $ 0.001 | $ 0.001 | | | | | | | |
Offering units | | | | | | | | | | | | 200,000 | | | | | | | | | | |
Offering price | | | | | | | | | | | | $ 25 | | | | | $ 25 | | | | | |
Percentage of preferred shares | | | | | | | | | | | | 7.75% | | | | | | | | | | |
Warrant exercise price per shares | | | | | | | | | | | | | | $ 8.75 | | | | $ 8.75 | | | | |
Series A convertible preferred share, description | | | | | | | | | | | | | | Each Series A Convertible Preferred Share is convertible into common shares at an initial conversion price of $5.60 per common share, or 4.46 common shares, at any time at the option of the holder, subject to certain customary adjustments | | | | | | | | |
Series A Convertible Preferred Shares - automatic conversion upon market trigger | | | | | | | | | | | | | | If the trading price of Pyxis Tankers’ common stock equals or exceeds $9.52 per share for at least 20 days in any 30 consecutive trading day period ending 5 days prior to notice, the Company can call, in whole or in part, for mandatory conversion of the Series A Convertible Preferred Shares | | | | | | | | |
Change of control terms line item | | | | | | | | | | | | | | In the case of a change of control that is pre-approved by the Company’s Board of Directors, holders of Series A Convertible Preferred Shares have the option to (i) demand that the Company redeem the Series A Convertible Preferred Shares at (a) $26.63 per Series A Convertible Preferred Share from the date of issuance until October 13, 2021, (b) $25.81 per Series A Convertible Preferred Share from October 13, 2021 until October 13, 2022 and (c) $25.00 after October 13, 2022, or (ii) continue to hold the Series A Convertible Preferred Shares. Upon a change of control, the holders also have the option to convert some or all of the Series A Convertible Preferred Shares, together with any accrued or unpaid dividends, into shares of common stock at the conversion rate. Change of Control means that (i) Mr. Valentios Valentis and his affiliates cease to own at least 20% of the voting securities of the Company, or (ii) a person or group acquires at least 50% voting control of the Company, and in the case of each of either (i) or (ii), neither the Company nor any surviving entity has its common stock listed on a recognized U.S. exchange | | | | | | | | |
Dividend distribution terms | | | | | | | | | | | | | | In addition, unless the Company has received the affirmative vote or consent of the holders of at least 66.67% of the then outstanding Series A Convertible Preferred Shares, voting as a single class, the Company may not create or issue any class or series of capital stock ranking senior to the Series A Convertible Preferred Shares with respect to dividends or distributions | | | | | | | | |
Description of warrant purchase | | | | | | | | | | | | | | On exercise, each Underwriter Warrant allows the holder to purchase one Series A Convertible Preferred Share or one Warrant to purchase one common share of the Company at $5.60 or, in case of absence of an effective registration statement, to exchange those cashless based on a formula set in the Underwriting Agreement. | | | | | | | | |
Gross proceeds from the Offering | | | | | | | | | | | | $ 5,000,000 | | | | | | | | | | |
Proceeds from offering | | | | | | | | | | | | $ 4,300,000 | | | | | | | | | | |
Class of warrant or right, outstanding | | | | | | | | | | | | | | | 1,590,540 | | | | | | | |
Class of warrant or right, number of securities called by each warrant or right | | | | | | | | | | | | | | 107,143 | | | | 107.1431 | | | | |
Warrants and rights outstanding, term | | | | | | | | | | | | | | 5 years | | | | 5 years | | | | |
Share price | | | | | | | | | | | | | | $ 3.75 | | | | | | | | |
General partners' offering costs | | | | | | | | | | | | | | | | | | | $ 250,000,000 | | | |
Bid price | | | | | $ 1 | | | | | | | | | | | | | | | | | |
Number of common stock issued, value | | | | | | | | | | | | | | | | $ 23,119,000 | | | | | | |
Reverse stock split, description | | | Following the Reverse Stock Split, our common shares continued trading on the Nasdaq Capital Markets under its existing symbol, “PXS”, with a new CUSIP number, 71726130. The payment for fractional share interests in connection with the Reverse Stock Split reduced the outstanding common shares to 10,613,424 post-Reverse Stock Split. The Reverse Stock Split was undertaken with the objective of meeting the minimum $1.00 per share requirement for maintaining the listing of the common shares on the Nasdaq Capital Markets. Furthermore, following the Reverse Stock Split, (a) the Conversion Price, as defined in the certification of designation of the Company’s 7.75% Series A Cumulative Convertible Preferred Shares (NASDAQ Cap Mkts: PXSAP), was adjusted from $1.40 to $5.60 and (b) the Exercise Price, as defined in the Company’s warrants to purchase common shares (NASDAQ Cap Mkts: PXSAW), was adjusted from $1.40 to $5.60. All the share and per share information for all periods presented has been adjusted to reflect the one for four Reverse Stock Split. | | | | | | | | | | | | | | | | | | | |
Stock repurchase program, authorized amount | | | | | | | | | | | | | | $ 2,000,000 | | | | | | | | |
Number of shares repurchased | | | | | | | | | | | | | | 331,591 | | | | | | | | |
Payments for commissions | | | | | | | | | | | | | | $ 1,200,000 | | | | | | | | |
Issuance of restricted common stock | | 55,000 | | | | | | | | | | | | | | | | | | | | |
Restricted shares grant date, value | | $ 201,000 | | | | | | | | | | | | 171,000 | | | | | | | | |
Compensation cost in general and administrative expenses | | 171,000 | | | | | | | | | | | | | | | | | | | | |
Subsequent Event [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Share price | $ 4.42 | | | | | | | | | | | | | | | | | | | | | |
Stock repurchased during period, shares | 44,557 | | | | | | | | | | | | | | | | | | | | | |
Cash | $ 197 | | | | | | | | | | | | | | | | | | | | | |
Restricted Stock [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Total unrecognized cost | | | | | | | | | | | | | | $ 30,000 | | | | | | | | |
Securities Purchase Agreement [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Number of common stock issued, shares | | | | | | | | | 3,571,429 | | | | | | | | | | | | | |
Proceeds from investors | | | | | | | | | $ 25,000,000 | | | | | | | | | | | | | |
Share price | | | | | | | | | $ 7 | | | | | | | | | | | | | |
Increase in common stock par or stated value per share | | | | | | | | $ 4 | | | | | | | | | | | | | | |
Adjustments to additional paid in capital, other | | | | | | | | $ 23,115,000 | | | | | | | | | | | | | | |
Underwriter's Warrants [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Warrant aggregate purchase price | | | | | | | | | | | | | $ 100,000 | | | | | | | | | |
First type - Warrant for the purchase of an aggregate Series A Convertible Preferred Shares | | | | | | | | | | | | | 2,000 | 4,683 | 4,683 | | | | | | | |
First - type exercise price | | | | | | | | | | | | | $ 24.92 | | | | | | | | | |
Second type - Warrant for the purchase of an aggregate Series A Convertible Preferred Shares | | | | | | | | | | | | | 4,000 | 3,460 | 4,000 | | | | | | | |
Second type - Exercise price | | | | | | | | | | | | | | | | | | | | | | $ 0.01 |
Termination date | | | | | | | | | | | | | at any time on or after April 6, 2021 and prior to October 8, 2025 | | | | | | | | | |
Conversion of stock, shares converted | | | | | | | | | | | | | | 45,842 | | | | | | | | |
Class of warrant or right, outstanding | | | | | | | | | | | | | | 3,460 | 4,000 | | | | | | | |
Series A Convertible Preferred Stock [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
First type - Warrant for the purchase of an aggregate Series A Convertible Preferred Shares | | | | | | | | | | | | | | 2,683 | | | | | | | | |
First - type exercise price | | | | | | | | | | | | | | $ 25 | | | | | | | | |
Second type - Warrant for the purchase of an aggregate Series A Convertible Preferred Shares | | | | | | | | | | | | | | 4,683 | 4,683 | | | | | | | |
Conversion of stock, shares converted | | | | | | | | | | | | | | | 200 | | | | | | | |
Common Stock [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Number of common stock issued, shares | | | | | | | | | | | | | | | | 3,571,429 | | | | | | |
Conversion of stock, shares converted | | | | | | | | | | | | | | 204,819 | 895 | | | | | | | |
Number of common stock issued, value | | | | | | | | | | | | | | | | $ 4,000 | | | | | | |
Number of shares repurchased | | | | | | | | | | | | | | (331,591) | | | | | | | | |
Issuance of restricted common stock | | | | | | | | | | | | | | 55,000 | | | | | | | | |
Restricted shares grant date, value | | | | | | | | | | | | | | | | | | | | | | |
Common Stock [Member] | Subsequent Event [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Stock repurchased during period, shares | 44,557 | | | | | | | | | | | | | | | | | | | | | |
Over-Allotment Option [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Additional number of Series A Convertible Preferred Shares (optional preferred shares) | | | | | | | | | | | | 30,000 | | | | | | | | | | |
Additional number of warrants (optional warrants) | | | | | | | | | | | | 240,000 | | | | | | | | | | |
Purchase price per optional preferred share | | | | | | | | | | | | $ 23.051 | | | | | | | | | | |
Purchase price per optional warrant | | | | | | | | | | | | $ 0.00925 | | | | | | | | | | |
Partial over allotment of warrants exercised by the underwriter | | | | | | | | | | | | 135,040 | | | | | | | | | | |
Gross proceeds | | | | | | | | | | | | $ 1,000 | | | | | | | | | | |
IPO [Member] | 7.75% Series A Cumulative Convertible Preferred Shares [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Proceeds from offering | | | | | $ 6,170,000 | | | | | | | | | | | | | | | | | |
Number of common stock issued, shares | | | | | 308,487 | | | | | | | | | | | | | | | | | |
Preference per share | | | | | $ 25 | | | | | | | | | | | | | | | | | |
Purchase price | | | | | $ 20 | | | | | | | | | | | | | | | | | |
Net of offering expense | | | | | $ 5,563,000 | | | | | | | | | | | | | | | | | |
Amended and Restated Promissory Note [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Number of common stock issued, shares | | | | | | | 11,957 | | | 16,112 | | | | | | | | | | | | |
Repayment of principal amount | | | | | | $ 1,000,000 | | | | | | | | | | | | | | | | |
Conversion of principal amount | | | | | | 1,000,000 | | | | | | | | | | | | | | | | |
Restructured principal amount | | | | | | $ 3,000,000 | | | | | | | | | | | | | | | | |
Maturity date | | | | | | Apr. 01, 2023 | | | | | | | | | | | | | | | | |
Accrue interest rate | | | | | | 7.50% | | | | | | | | | | | | | | | | |
Amended and Restated Promissory Note [Member] | Restricted Stock [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Number of common stock issued, shares | | | | | | 272,766 | | | | | | | | | | | | | | | | |
Maximum [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Stock repurchase program, authorized amount | | $ 2,000,000 | | | | | | | | | | | | | | | | | | | | |
Series A Convertible Preferred Shares [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Common stock, shares authorized | | | | | | | | | | | | | | 1,000,000 | 1,000,000 | | | | | | | |
Preferred stock, shares issued | | | | | | | | | | | | | | 403,631 | 449,473 | | | | | | | |
Preferred stock, shares outstanding | | | | | | | | | | | | | | 403,631 | 449,473 | | | | | | | |
Class of warrant or right, outstanding | | | | | | | | | | | | | | 1,591,062 | | | | | | | | |
Series A Convertible Preferred Shares and Detachable Warrants [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Warrant exercise price per shares | | | | | | | | | | | | $ 5.60 | | | | | | | | | | |
Warrant exercisable date | | | | | | | | | | | | at any time prior to October 13, 2025 or, in case of absence of an effective registration statement, to exchange those cashless based on a formula | | | | | | | | | | |
Annual cash dividend per share | | | | | | | | | | | | | | $ 1.9375 | | | | | | | | |
Preferred dividend percentage | | | | | | | | | | | | 7.75% | | | | | | | | | | |
Liquidation preference per share | | | | | | | | | | | | | | 25 | | | | | | | | |
Cash dividend per share | | | | | | | | | | | | | | | | | | | | $ 0.1615 | $ 0.1991 | |
Monthly cash dividend paid per share | | | | | | | | | | | | | | $ 0.1615 | $ 0.1615 | $ 0.1615 | | | | | | |
Dividend payable | | | | | | | | | | | | | | $ 797,000 | $ 871,000 | $ 537,000 | | | | | | |
Series A Convertible Preferred Shares and Detachable Warrants [Member] | Maximum [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Common shares from exerciseable of detachable warrants | | | | | | | | | | | | 1,600,000 | | | | | | | | | | |
Series A Preferred Stock [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Share price | | | | | | | | | | | | | | $ 25 | | | | | | | | |
Common Stock [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Number of common stock issued, shares | | | | 1,034,751 | | | | | | | | | | | | | | | | | | |
Share price | | | | $ 2.90 | | | | | | | | | | | | | | | | | | |
Common Stock [Member] | Pyxis Lamda [Member] | | | | | | | | | | | | | | | | | | | | | | |
Defined Benefit Plan Disclosure [Line Items] | | | | | | | | | | | | | | | | | | | | | | |
Number of common stock issued, shares | | | | | | | | | | | 1,034,751 | | | | | | | | | | | |
Number of common stock issued, value | | | | | | | | | | | $ 2,172,000 | | | | | | | | | | | |